SABBY 13G HEPA 2.19.21

Company

Hepion Pharmaceuticals, Inc.

Filed

February 19, 2021

Accession Number

0001535610-21-000079

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →